The Discounted Cash Flow (DCF) valuation of Bioventus Inc (BVS) is 15.41 USD. With the latest stock price at 10.65 USD, the upside of Bioventus Inc based on DCF is 44.7%.
Based on the latest price of 10.65 USD and our DCF valuation, Bioventus Inc (BVS) is a buy. buying Bioventus stocks now will result in a potential gain of 44.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 9.7% | 8.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 9.67 - 32.42 | 15.41 |
| Upside | -9.2% - 204.4% | 44.7% |